文献速递外周动脉疾病

外周动脉疾病高成本住院患者的特征分析

Characteristics of high-cost inpatients with peripheral artery disease.
PubMed 文献 · J Vasc Surg · 2020-01-21

费用最高的10%患者平均费用为88076美元,是非高费用患者平均费用16217美元的五倍以上。高费用与紧急就诊、不良安全事件、截肢、ICU入住、出院障碍及杂交血运重建相关,且高费用组院内死亡率高于预测值。

要点

  • 费用最高的10%外周动脉疾病住院患者平均费用达88076美元,为非高费用患者的五倍以上。
  • 高费用患者更易发生不良安全事件(OR 13.49)、截肢(OR 2.79)、ICU入住(OR 6.42)和出院障碍(OR 10.44)。
  • 高费用组院内死亡率为18%,高于预测的9.2%,且不足半数患者出院回家。

核心结论

  • 费用最高的10%外周动脉疾病住院患者人均费用为非高费用患者的五倍以上。
  • 入院期间存在潜在可干预因素可能降低高费用患者的费用。

研究设计与样本

  • 回顾性队列研究,纳入2007至2016年渥太华医院因外周动脉疾病接受手术的3084例住院患者。
  • 收集人口学、合并症、住院事件及住院费用数据,高费用定义为费用位于第十百分位及以上。

主要发现

  • 高费用患者平均费用为88076美元(标准差54720),非高费用患者平均费用为16217美元(标准差10322)。

临床怎么用

  • 识别高费用外周动脉疾病住院患者的特征有助于资源规划和费用控制。
  • 关注入院期间可干预因素如不良安全事件、出院障碍可能降低高费用风险。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Inpatient treatment of peripheral artery disease (PAD) is more than six times as costly as that of the general inpatient population. Our objective was to describe factors associated with hospital cost for patients admitted for PAD, the characteristics of high-cost patients, and their outcomes including amputations and death. METHODS: We performed a retrospective cohort study of admitted patients receiving a procedure for PAD at The Ottawa Hospital between 2007 and 2016. Demographics, comorbidity, inpatient events, and hospital cost data during the index admission were collected. We defined high-cost patients as those whose total costs of index admission were in the tenth percentile and above. Features associated with high-cost status were examined using logistic regression with elastic net regularization. We used generalized linear models to examine overall drivers of cost. RESULTS: We identified 3084 eligible patients, incurring $72.2 million in hospital costs. The mean cost of the most expensive 10% of patients was $88,076 (standard deviation, $54,720), more than five times the mean cost of $16,217 (standard deviation, $10,322) for nonhigh-cost patients. High-cost patients were more likely to present urgently (odds ratio [OR], 1.63; 95% confidence interval [CI], 1.16-2.25; P < .01). After adjustment for preadmission factors, high-cost patients were more likely to have experienced an adverse patient safety incident (OR, 13.49; 95% CI, 6.97-24.8; P < .01), amputation (OR, 2.79; 95% CI, 1.68-4.49; P <.01), intensive care unit admission (OR, 6.42; 95% CI, 3.62-10.2; P < .01), and disposition barriers requiring alternate level of care status (OR, 10.44; 95% CI, 6.42-15.2; P < .01). The high-cost group was more likely to have received hybrid revascularization (OR, 7.07; 95% CI, 3.34-13.6; P < .01). High-cost patients had higher than predicted in-hospital mortality (18% vs 9.2% predicted) compared with the low-cost group (3.0% vs 2.7%; P < .001), and fewer than half of high-cost patients were discharged home. CONCLUSIONS: Providing hospital care for the top 10% most expensive patients in our cohort was more than five times as costly per patient than providing care for the nonhigh-cost patients. Whereas pre-existing factors may predispose a patient to require expensive care, there are potentially modifiable factors during the admission that could reduce costs of these patients.

来源:J Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Rockley M, Kobewka D, Kunkel E, et al. Characteristics of high-cost inpatients with peripheral artery disease. J Vasc Surg. 2020. PMID: 31980246. doi:10.1016/j.jvs.2019.09.054

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。